Last reviewed · How we verify
BAY1817080 - Formulation B
At a glance
| Generic name | BAY1817080 - Formulation B |
|---|
| Sponsor | Bayer |
|---|
| Modality | Small molecule |
|---|
| Phase | Phase 1 |
|---|
Approved indications
No approved indications tracked.
Common side effects
No common side effects on file.